These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 15308518

  • 1. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
    Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B, BARFOT Study Group.
    Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
    [Abstract] [Full Text] [Related]

  • 2. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [Abstract] [Full Text] [Related]

  • 3. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
    Kaltenhäuser S, Pierer M, Arnold S, Kamprad M, Baerwald C, Häntzschel H, Wagner U.
    Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
    [Abstract] [Full Text] [Related]

  • 4. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
    Reneses S, González-Escribano MF, Fernández-Suárez A, Pestana L, Davila B, Wichmann I, García A.
    J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
    [Abstract] [Full Text] [Related]

  • 5. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK.
    Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
    [Abstract] [Full Text] [Related]

  • 6. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Kuru O, Bilgici A, Birinci A, Ulusoy H, Durupinar B.
    Bratisl Lek Listy; 2009 Jul; 110(10):650-4. PubMed ID: 20017459
    [Abstract] [Full Text] [Related]

  • 8. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
    Syversen SW, Goll GL, van der Heijde D, Landewé R, Lie BA, Odegård S, Uhlig T, Gaarder PI, Kvien TK.
    Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.
    Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA.
    J Rheumatol; 2011 Jan; 38(1):44-52. PubMed ID: 20952476
    [Abstract] [Full Text] [Related]

  • 10. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR.
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [Abstract] [Full Text] [Related]

  • 11. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E, Eberhardt K, Bendtzen K, Heinegård D, Saxne T.
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [Abstract] [Full Text] [Related]

  • 12. Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking.
    Roos K, Martinsson K, Ziegelasch M, Sommarin Y, Svärd A, Skogh T, Kastbom A.
    Arthritis Res Ther; 2016 May 23; 18(1):119. PubMed ID: 27215344
    [Abstract] [Full Text] [Related]

  • 13. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
    Quinn MA, Gough AK, Green MJ, Devlin J, Hensor EM, Greenstein A, Fraser A, Emery P.
    Rheumatology (Oxford); 2006 Apr 23; 45(4):478-80. PubMed ID: 16287917
    [Abstract] [Full Text] [Related]

  • 14. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS.
    Rheumatology (Oxford); 2007 Feb 23; 46(2):342-9. PubMed ID: 16899498
    [Abstract] [Full Text] [Related]

  • 15. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E.
    Clin Exp Rheumatol; 2006 Feb 23; 24(3):281-6. PubMed ID: 16870095
    [Abstract] [Full Text] [Related]

  • 16. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH.
    Ann Rheum Dis; 2009 Feb 23; 68(2):201-8. PubMed ID: 18390910
    [Abstract] [Full Text] [Related]

  • 17. A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicine.
    de Punder YM, van Riel PL, Fransen J.
    J Rheumatol; 2015 Mar 23; 42(3):391-7. PubMed ID: 25593237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, Dijkmans BA, Hamann D.
    Ann Rheum Dis; 2005 Aug 23; 64(8):1199-204. PubMed ID: 15640269
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.
    Vencovský J, Machácek S, Sedová L, Kafková J, Gatterová J, Pesáková V, Růzicková S.
    Ann Rheum Dis; 2003 May 23; 62(5):427-30. PubMed ID: 12695154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.